BlackRock Investment Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$163K Hold
7,585
﹤0.01% 3243
2016
Q3
$581K Buy
7,585
+787
+12% +$57.4K ﹤0.01% 2970
2016
Q2
$513K Buy
6,798
+567
+9% +$45.6K ﹤0.01% 3056
2016
Q1
$543K Buy
6,231
+109
+2% +$9.54K ﹤0.01% 2867
2015
Q4
$723K Buy
6,122
+10
+0.2% +$992 ﹤0.01% 2810
2015
Q3
$538K Sell
6,112
-90
-1% -$10.5K ﹤0.01% 2997
2015
Q2
$672K Buy
6,202
+3,104
+100% +$386K ﹤0.01% 3015
2015
Q1
$391K Buy
3,098
+657
+27% +$85.4K ﹤0.01% 3049
2014
Q4
$310K Buy
2,441
+9
+0.4% +$1.25K ﹤0.01% 3179
2014
Q3
$326K Sell
2,432
-81
-3% -$11.3K ﹤0.01% 3155
2014
Q2
$409K Sell
2,513
-184
-7% -$31.3K ﹤0.01% 3123
2014
Q1
$596K Buy
2,697
+303
+13% +$77.3K ﹤0.01% 2858
2013
Q4
$617K Buy
+2,394
New +$548K ﹤0.01% 2847

Other funds holding TNDM

BlackRock Investment Management's TNDM Position: Q4 2016 in Review

BlackRock Investment Management held its Tandem Diabetes Care (TNDM) position steady in Q4 2016 at 7,585 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #3243.

BlackRock Investment Management first reported a position in TNDM in Q4 2013 and has held it in 13 quarters since. The position peaked at $723K in Q4 2015. 75 funds tracked by Wall St. Rank hold TNDM as of Q4 2016.

  • BlackRock Investment Management held 7,585 shares of Tandem Diabetes Care worth $163K as of Q4 2016.
  • BlackRock Investment Management left its Tandem Diabetes Care share count unchanged in Q4 2016.
  • Tandem Diabetes Care made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3243 holding.
  • BlackRock Investment Management first reported a position in Tandem Diabetes Care in Q4 2013 and has held it in 13 quarters since.
  • BlackRock Investment Management's Tandem Diabetes Care position peaked at $723K in Q4 2015.
  • 75 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.